About the meeting
The ICCBH biennial conference is firmly established on the international meeting calendar and regularly attracts audiences in excess of 600 delegates to hear about and discuss the latest research into paediatric bone disorders. The next ICCBH conference is due to take place in Dublin, Ireland, on 3-6 July 2021. Our focus is on supporting this growing community. In view of this a new Bone School is scheduled to take place immediately prior to the Dublin meeting. In addition, due to the Covid-19 pandemic a virtual meeting on bone fragility disorders will be organised for 18-20 November 2020.
The Virtual Forum will comprise invited lectures, meet the expert sessions, workshops, clinical case discussions, oral communications, poster discussions and networking sessions.
The aim is to present and discuss new research in investigative, diagnostic and therapeutic management of patients with bone fragility disorders and to foster the exchange of ideas and discussion of ongoing initiatives.
The focus will be on provision of engaging content and networking opportunities for a global audience.
The meeting is organised in association with ECTS, OIF and OIFE. OIF will organise a Virtual Young Investigators’ Symposium as a pre-meeting to the ICCBH Virtual Forum. Details on the OIF website.
Scientific programme overview
Times shown are Central European Time (eg 15:00 Paris = 14:00 London, 09:00 Washington DC, 06:00 San Francisco, 23:00 Sydney).
Sessions will be recorded and made available for delegates to revisit or to view in their own time.
Download a printable version of the programme from here
Continuing Medical Education (CME)
CME accreditation has been applied for
Guidelines for speakers and poster presenters
Guidelines will be posted in October 2020
Abstract and clinical case submission
Deadline for abstracts and clinical cases: 1 October 2020
Research abstracts and clinical cases are invited. There are no abstract submission fees. Work which has been previously presented may be submitted provided it hasn’t already been published as a full paper.
Abstracts will be published in JBMR Plus.
Presenting at the virtual forum will give you an opportunity to network with a global audience and in particular to:
- Showcase your current work
- Get support and feedback from others
- Raise your profile among colleagues internationally and from multiple disciplines
- Widen your network to open up new opportunities for future collaborations
Abstract submission guidelines are available here
As mentioned above, OIF will organise a Virtual Young Investigators’ Symposium as a pre-meeting to the ICCBH Virtual Forum, on 17 November. Any abstracts submitted to the OIF meeting may also be submitted to ICCBH and vice versa. Details of how to submit abstracts for consideration for the OIF meeting are on the OIF website.
New Investigator Awards
Two New Investigator Awards will be offered according to mean score achieved during the blind reviewing process. Awards winners will be notified by email on 16 October 2020.
To be eligible an author must be:
- First and presenting author
- Must be in training or within 3 years of attaining PhD or MD or equivalent and/or aged under 35
There is a box on the abstract form for confirmation of eligibility.
Best Poster Awards
In addition there will be awards for the two Best Posters, as selected by the meeting attendees.
Standard registration: €150
Reduced registration: €90*
A late registration fee of €30 will apply to registrations received after 23:59 CET on 30 October 2020.
To register at the discounted rate you must be one of the following:
- an undergraduate
- a current MD/PhD student
- within 5 years of obtaining an MD/PhD
- an Allied Health Professional
- a registered patient group representative*
- based in a low or developing income country (see list)
The meeting programme is designed for healthcare professionals and researchers. Pharma industry regulations do not allow open invitations to members of the public to attend. However, patient organisation representatives are encouraged to register to attend the meeting provided they meet the following criteria:
- They represent a formally registered international organisation with elections (or national with some international activities) and
- They are a member of the management group or are officially nominated by the management group or are a paid member of staff
Cancellations will be accepted in writing until 23:59 on Friday 6 November, until which time a 70% refund will be given. There will be no refunds for cancellations received after this date.
Any Italian pharmaceutical company supporting or participating in a congress abroad, is subjected to an authorization by AIFA (Italian Drug Agency), according to an Italian Government Decree (Decreto Legislativo 219/06 – art. 124).
The authorisation request must be submitted within 70 days before the start date of the event. The appointed agency to collect all applications from pharmaceutical companies and file them with the AIFA is:
Alijet & Fargo International Srl
Via P. Maroncelli 44-46-48-50
50137 FIRENZE, Italy
The meeting will offer a high quality scientific programme of interest to both clinical and basic scientists.
Attendees will be from a multidisciplinary background, including paediatricians, endocrinologists, rheumatologists, nephrologists, nutritionists, orthopaedic surgeons and others, giving you the opportunity to raise your profile with a broad global audience.
To discuss please contact us.
1 October 2020
16 October 2020
30 October 2020
16 November 2020
18-20 November 2020
Confirmations to authors
Late registration period begins
Frank Rauch (Montreal, Canada) (Meeting Chair)
Nick Bishop (Sheffield, UK)
Alison Boyce (Bethesda, US)
Antonella Forlino (Pavia, Italy)
Gabriele Häusler (Vienna, Austria)
Wolfgang Högler (Linz, Austria)
Alex Ireland (Manchester, UK)
Outi Mäkitie (Helsinki, Finland)
Ciara McDonnell (Dublin, Ireland)
Craig Munns (Sydney, Australia)
Leanne Ward (Ottawa, Canada)